| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | Mar 26, 2024 | Option Exercise | $1.57 | 109,768 | 172,874 | 634,249 | Mar 28, 2024, 07:12 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Mar 19, 2024 | Sale | $2.09 | 5,268 | 10,986 | 117,728 | Mar 21, 2024, 04:41 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | Mar 19, 2024 | Sale | $2.09 | 20,223 | 42,175 | 524,481 | Mar 21, 2024, 04:40 PM | |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | SVP, Finance and Accounting | Mar 19, 2024 | Sale | $2.09 | 2,971 | 6,196 | 85,686 | Mar 21, 2024, 04:38 PM | |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | Mar 19, 2024 | Sale | $2.09 | 12,795 | 26,684 | 168,579 | Mar 21, 2024, 04:37 PM | |
| CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Officer | Mar 19, 2024 | Sale | $2.09 | 6,562 | 13,685 | 110,060 | Mar 21, 2024, 04:36 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | Dec 20, 2023 | Sale | $1.38 | 13,551 | 18,710 | 454,704 | Dec 22, 2023, 04:16 PM | |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | Dec 20, 2023 | Sale | $1.38 | 4,077 | 5,628 | 155,124 | Dec 22, 2023, 04:14 PM | |
| CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Officer | Dec 20, 2023 | Sale | $1.38 | 4,077 | 5,628 | 86,622 | Dec 22, 2023, 04:12 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Dec 20, 2023 | Sale | $1.38 | 4,077 | 5,629 | 97,996 | Dec 22, 2023, 04:11 PM | |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | SVP, Finance and Accounting | Dec 20, 2023 | Sale | $1.38 | 1,990 | 2,747 | 48,657 | Dec 22, 2023, 04:10 PM | |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | Sep 22, 2023 | Sale | $1.30 | 4,119 | 5,356 | 147,951 | Sep 22, 2023, 07:16 PM | |
| CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Officer | Sep 22, 2023 | Sale | $1.30 | 4,119 | 5,356 | 76,379 | Sep 22, 2023, 07:15 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | Sep 22, 2023 | Sale | $1.30 | 14,601 | 18,987 | 430,755 | Sep 22, 2023, 07:13 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Sep 22, 2023 | Sale | $1.30 | 5,486 | 7,135 | 80,609 | Sep 22, 2023, 07:12 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | May 19, 2023 | Option Exercise | $1.57 | 16,535 | 26,041 | 405,356 | May 23, 2023, 04:52 PM | |
| CTMX | CytomX Therapeutics, Inc. | Jones Elaine V | Director | Mar 29, 2023 | Buy | $1.55 | 5,000 | 7,750 | 5,142 | Mar 31, 2023, 07:56 PM | |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | SVP, Finance and Accounting | Mar 16, 2023 | Sale | $1.98 | 516 | 1,021 | 37,772 | Mar 20, 2023, 06:43 PM | |
| CTMX | CytomX Therapeutics, Inc. | Campoy Carlos | Chief Financial Officer | Mar 16, 2023 | Sale | $1.98 | 1,748 | 3,459 | 38,224 | Mar 20, 2023, 06:43 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | Mar 16, 2023 | Sale | $1.88 | 7,121 | 13,391 | 388,821 | Mar 20, 2023, 06:43 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Mar 16, 2023 | Sale | $1.98 | 2,037 | 4,031 | 71,095 | Mar 20, 2023, 06:43 PM | |
| CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Financial Officer | Mar 16, 2023 | Sale | $1.98 | 1,477 | 2,923 | 69,248 | Mar 20, 2023, 06:43 PM | |
| CTMX | CytomX Therapeutics, Inc. | Peterson Amy C. | EVP, Chief Development Officer | Mar 16, 2023 | Sale | $1.98 | 4,257 | 8,425 | 58,433 | Mar 20, 2023, 06:43 PM | |
| CTMX | CytomX Therapeutics, Inc. | Peterson Amy C. | EVP, Chief Development Officer | Jul 20, 2022 | Sale | $1.42 | 7,463 | 10,612 | 62,690 | Jul 21, 2022, 04:11 PM | |
| CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Officer | Jul 20, 2022 | Sale | $1.42 | 4,206 | 5,982 | 30,725 | Jul 21, 2022, 04:11 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Jul 20, 2022 | Sale | $1.42 | 14,911 | 21,206 | 290,942 | Jul 21, 2022, 04:10 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Jul 20, 2022 | Sale | $1.42 | 5,602 | 7,968 | 43,689 | Jul 21, 2022, 04:10 PM | |
| CTMX | CytomX Therapeutics, Inc. | HANNAH ALISON L. | Chief Medical Officer | Jul 20, 2022 | Sale | $1.42 | 5,602 | 7,965 | 31,898 | Jul 21, 2022, 04:09 PM | |
| CTMX | CytomX Therapeutics, Inc. | Campoy Carlos | Chief Financial Officer | Jul 20, 2022 | Sale | $1.42 | 3,949 | 5,617 | 39,972 | Jul 21, 2022, 04:08 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | May 09, 2022 | Option Exercise | $0.94 | 90,931 | 85,930 | 265,853 | May 11, 2022, 04:51 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Aug 11, 2021 | Option Exercise | $1.13 | 92,113 | 104,447 | 99,922 | Aug 13, 2021, 05:22 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Jun 14, 2021 | Option Exercise | $1.09 | 40 | 43 | 7,849 | Jun 16, 2021, 09:49 PM | |
| CTMX | CytomX Therapeutics, Inc. | Campoy Carlos | Chief Financial Officer | May 31, 2021 | Option Exercise | $6.09 | 3,320 | 20,206 | 6,421 | Jun 08, 2021, 01:08 PM | |
| CTMX | CytomX Therapeutics, Inc. | Peterson Amy C. | EVP, Chief Development Officer | May 31, 2021 | Option Exercise | $6.09 | 3,320 | 20,206 | 6,421 | Jun 08, 2021, 01:07 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Dec 23, 2020 | Option Exercise | $1.13 | 100,000 | 113,390 | 206,894 | Dec 28, 2020, 07:52 PM | |
| CTMX | CytomX Therapeutics, Inc. | Peterson Amy C. | EVP, Chief Development Officer | Nov 30, 2020 | Option Exercise | $6.39 | 3,101 | 19,822 | 3,101 | Dec 07, 2020, 04:59 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Nov 30, 2020 | Option Exercise | $6.39 | 930 | 5,945 | 106,894 | Dec 07, 2020, 04:58 PM | |
| CTMX | CytomX Therapeutics, Inc. | Campoy Carlos | Chief Financial Officer | Nov 30, 2020 | Option Exercise | $6.39 | 3,101 | 19,822 | 3,101 | Dec 07, 2020, 04:57 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Sep 21, 2020 | Option Exercise | $6.61 | 20,500 | 135,601 | 105,964 | Sep 23, 2020, 04:53 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | May 29, 2020 | Option Exercise | $5.11 | 1,158 | 5,916 | 85,464 | Jun 02, 2020, 04:54 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | May 12, 2020 | Sale | $8.07 | 72,000 | 580,820 | 120,306 | May 14, 2020, 04:31 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Nov 30, 2019 | Option Exercise | $5.32 | 1,080 | 5,747 | 84,306 | Dec 16, 2019, 04:20 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | May 31, 2019 | Option Exercise | $8.21 | 1,812 | 14,878 | 11,791 | Jun 04, 2019, 04:08 PM | |
| CTMX | CytomX Therapeutics, Inc. | Knifsend Robin | Principal Accounting Officer | May 31, 2019 | Option Exercise | $8.21 | 1,812 | 14,878 | 2,791 | Jun 04, 2019, 04:06 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | May 31, 2019 | Option Exercise | $8.21 | 695 | 5,707 | 83,226 | Jun 04, 2019, 04:04 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Mar 04, 2019 | Buy | $10.33 | 9,000 | 92,970 | 9,979 | Mar 05, 2019, 12:00 AM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Dec 12, 2018 | Option Exercise | $8.22 | 6,000 | 49,347 | 8,928 | Dec 14, 2018, 03:23 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Nov 30, 2018 | Option Exercise | $11.73 | 468 | 5,490 | 82,531 | Dec 06, 2018, 01:57 PM | |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | Nov 30, 2018 | Option Exercise | $11.73 | 979 | 11,484 | 979 | Dec 06, 2018, 01:55 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Nov 01, 2018 | Option Exercise | $8.22 | 6,000 | 49,347 | 8,928 | Nov 05, 2018, 04:15 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Nov 01, 2018 | Sale | $8.29 | 10,740 | 89,008 | 87,433 | Nov 05, 2018, 04:14 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Nov 02, 2018 | Option Exercise | $8.29 | 2,312 | 19,169 | 83,219 | Nov 05, 2018, 04:14 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Oct 01, 2018 | Option Exercise | $9.95 | 6,000 | 59,727 | 8,928 | Oct 02, 2018, 03:18 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Sep 04, 2018 | Option Exercise | $11.92 | 6,000 | 71,517 | 8,928 | Sep 06, 2018, 07:18 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Sep 04, 2018 | Option Exercise | $11.72 | 26,104 | 305,898 | 95,115 | Sep 06, 2018, 07:14 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Aug 01, 2018 | Option Exercise | $13.66 | 6,000 | 81,985 | 8,928 | Aug 02, 2018, 08:55 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Jul 05, 2018 | Sale | $13.32 | 8,994 | 119,771 | 86,560 | Jul 09, 2018, 06:15 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Jul 03, 2018 | Sale | $13.33 | 4,056 | 54,074 | 84,091 | Jul 06, 2018, 06:52 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Jul 02, 2018 | Sale | $11.91 | 6,000 | 71,460 | 8,928 | Jul 03, 2018, 06:51 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Jul 02, 2018 | Option Exercise | $12.50 | 26,104 | 326,263 | 95,115 | Jul 03, 2018, 06:50 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | May 31, 2018 | Option Exercise | $17.90 | 1,187 | 21,248 | 5,928 | Jun 05, 2018, 07:46 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Jun 01, 2018 | Option Exercise | $13.60 | 6,000 | 81,573 | 8,928 | Jun 05, 2018, 07:46 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | May 31, 2018 | Option Exercise | $17.90 | 302 | 5,406 | 4,945 | Jun 05, 2018, 07:45 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | May 01, 2018 | Option Exercise | $13.89 | 6,000 | 83,342 | 7,741 | May 02, 2018, 06:26 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | May 01, 2018 | Option Exercise | $14.06 | 39,156 | 550,576 | 24,221 | May 02, 2018, 06:25 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Apr 02, 2018 | Option Exercise | $14.69 | 6,000 | 88,140 | 7,741 | Apr 04, 2018, 02:27 PM | |
| CTMX | CytomX Therapeutics, Inc. | GLUCK FREDERICK W | Director | Mar 26, 2018 | Sale | $31.93 | 5,000 | 159,642 | 271,643 | Mar 27, 2018, 08:54 PM | |
| CTMX | CytomX Therapeutics, Inc. | GLUCK FREDERICK W | Director | Mar 02, 2018 | Sale | $30.00 | 16,181 | 485,466 | 276,643 | Mar 05, 2018, 07:01 PM | |
| CTMX | CytomX Therapeutics, Inc. | HUMPHREY RACHEL | Chief Medical Officer | Mar 02, 2018 | Sale | $18.31 | 32,320 | 591,694 | 46,394 | Mar 05, 2018, 06:59 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Mar 01, 2018 | Sale | $15.40 | 39,156 | 602,967 | 24,221 | Mar 05, 2018, 12:00 AM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Mar 01, 2018 | Sale | $15.33 | 26,000 | 398,620 | 17,741 | Mar 05, 2018, 12:00 AM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Mar 02, 2018 | Sale | $15.77 | 40,000 | 630,826 | 19,226 | Mar 05, 2018, 12:00 AM | |
| CTMX | CytomX Therapeutics, Inc. | HUMPHREY RACHEL | Chief Medical Officer | Feb 28, 2018 | Option Exercise | $18.31 | 47,680 | 872,894 | 54,074 | Mar 02, 2018, 11:55 AM | |
| CTMX | CytomX Therapeutics, Inc. | GLUCK FREDERICK W | Director | Feb 28, 2018 | Sale | $30.00 | 3,819 | 114,570 | 292,824 | Mar 02, 2018, 11:54 AM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Feb 01, 2018 | Sale | $26.69 | 2,548 | 68,010 | 4,741 | Feb 02, 2018, 07:28 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Jan 05, 2018 | Option Exercise | $13.07 | 13,052 | 170,615 | 11,169 | Jan 09, 2018, 11:20 AM | |
| CTMX | CytomX Therapeutics, Inc. | GLUCK FREDERICK W | Director | Jan 05, 2018 | Sale | $25.01 | 10,000 | 250,078 | 296,643 | Jan 08, 2018, 05:47 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Jan 02, 2018 | Option Exercise | $11.09 | 26,104 | 289,414 | 17,695 | Jan 04, 2018, 12:25 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Jan 02, 2018 | Sale | $21.11 | 2,500 | 52,775 | 7,289 | Jan 03, 2018, 03:23 PM | |
| CTMX | CytomX Therapeutics, Inc. | GLUCK FREDERICK W | Director | Dec 26, 2017 | Sale | $22.29 | 5,000 | 111,426 | 306,643 | Dec 28, 2017, 05:56 PM | |
| CTMX | CytomX Therapeutics, Inc. | HUMPHREY RACHEL | Chief Medical Officer | Dec 15, 2017 | Option Exercise | $6.61 | 15,117 | 99,994 | 30,234 | Dec 19, 2017, 12:23 PM | |
| CTMX | CytomX Therapeutics, Inc. | Kavanaugh William Michael | CSO, Head Res.&Non-Clin. Dev. | Dec 08, 2017 | Option Exercise | $1.57 | 5,130 | 8,079 | 19,047 | Dec 12, 2017, 02:35 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Nov 30, 2017 | Option Exercise | $12.15 | 163 | 1,980 | 12,289 | Dec 05, 2017, 12:56 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Dec 01, 2017 | Sale | $20.58 | 2,500 | 51,450 | 9,789 | Dec 05, 2017, 12:56 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Nov 30, 2017 | Option Exercise | $12.15 | 398 | 4,834 | 4,643 | Dec 05, 2017, 12:55 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Dec 01, 2017 | Option Exercise | $10.84 | 28,680 | 310,890 | 18,983 | Dec 05, 2017, 12:55 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Nov 01, 2017 | Option Exercise | $10.40 | 28,684 | 298,385 | 18,587 | Nov 03, 2017, 04:34 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Nov 01, 2017 | Sale | $20.00 | 2,500 | 50,000 | 12,126 | Nov 03, 2017, 04:33 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Oct 04, 2017 | Sale | $12.54 | 38,240 | 479,434 | 23,365 | Oct 06, 2017, 06:37 PM | |
| CTMX | CytomX Therapeutics, Inc. | Kavanaugh William Michael | CSO, Head Res.&Non-Clin. Dev. | Oct 04, 2017 | Option Exercise | $14.41 | 96,736 | 1,393,618 | 62,285 | Oct 06, 2017, 12:20 PM | |
| CTMX | CytomX Therapeutics, Inc. | GLUCK FREDERICK W | Director | Oct 04, 2017 | Sale | $24.27 | 10,000 | 242,680 | 311,643 | Oct 06, 2017, 12:18 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Oct 02, 2017 | Sale | $9.76 | 19,124 | 186,602 | 13,807 | Oct 04, 2017, 07:56 PM | |
| CTMX | CytomX Therapeutics, Inc. | TEPPER ROBERT I | 10% Owner | Oct 04, 2017 | Sale | $24.34 | 24,777 | 603,072 | 29,516 | Oct 04, 2017, 04:09 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Oct 02, 2017 | Sale | $18.10 | 2,500 | 45,250 | 14,626 | Oct 04, 2017, 12:38 PM | |
| CTMX | CytomX Therapeutics, Inc. | GLUCK FREDERICK W | Director | Sep 26, 2017 | Sale | $17.30 | 5,000 | 86,476 | 321,643 | Sep 27, 2017, 04:12 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Sep 01, 2017 | Sale | $9.14 | 19,860 | 181,438 | 14,175 | Sep 22, 2017, 02:59 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Aug 31, 2017 | Sale | $9.22 | 37,512 | 345,984 | 23,001 | Sep 22, 2017, 02:58 PM | |
| CTMX | CytomX Therapeutics, Inc. | TEPPER ROBERT I | 10% Owner | Sep 19, 2017 | Sale | $18.00 | 20,000 | 360,000 | 54,293 | Sep 21, 2017, 04:00 PM | |
| CTMX | CytomX Therapeutics, Inc. | RAY DEBANJAN | Chief Financial Officer | Sep 01, 2017 | Sale | $17.17 | 2,500 | 42,925 | 17,126 | Sep 05, 2017, 06:18 PM | |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | President and CEO | Sep 01, 2017 | Option Exercise | $9.13 | 19,860 | 181,371 | 14,175 | Sep 05, 2017, 06:17 PM |
Menu